4Waterbor JW, Bueschen AJ. Prostate cancer screening (United States). Cancer Casues Control, 1995, 6(3) : 267-274.
5Parker SL, Tong T, Bolden S, et 81. Cancer Statisis, CA cancer J Clin, 1997, 47: 5-27.
6Fan Jin, Susan S, Wei Zheng, et al. Cancer incidence trends in urban shanghai. Int J Cancer, 1993, 53: 764-770.
7Tulinius H. Latent malignancies at autopsy: a little used source of information on cancer biology. IARC Sei Publ, 1991, 112:253-261.
8Silvestri F, Bussani R, Pavletic N, et al. Neoplastic and borderline lesion of the prostate: autopsy study and epidemiological data. Pathol Res Pratt, 1995, 191(9): 908-916.
9Mebance C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Nad Med Assoc, 1990, 82(11) : 782-788.
10Demark Wahnefried W, Schildkraut JM, Iselin CE, et al.Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer, 1998, 83(2): 320-330.
